UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
SiriusPoint
SPNT
$2.68B
| $476K | ﹤0.01% |
63,367
-14,761
| -19% | -$111K |
|
2102
Harmonic Inc
HLIT
$1.28B
| $474K | ﹤0.01% |
99,753
+5,800
| +6% | +$32.4K |
|
2103
Center Bancorp
CNOB
$1.78B
| $473K | ﹤0.01% |
29,352
-4,037
| -12% | -$57.6K |
|
2104
BrightView Holdings
BV
$1.07B
| $470K | ﹤0.01% |
41,921
+6,300
| +18% | +$76.3K |
|
|
TPC
2105
Tutor Perini Cor
TPC
$5.21B
| $469K | ﹤0.01% |
38,540
-21,735
| -36% | -$194K |
|
2106
Omega Flex
OFLX
$312M
| $469K | ﹤0.01% |
+4,429
| New | +$421K |
|
2107
Viper Energy
VNOM
$14.7B
| $468K | ﹤0.01% |
45,200
+3,000
| +7% | +$28.8K |
|
|
MOBL
2108
DELISTED
MobileIron, Inc.
MOBL
| $466K | ﹤0.01% |
94,541
+36,422
| +63% | +$167K |
|
|
BRSP
2109
BrightSpire Capital
BRSP
$648M
| $465K | ﹤0.01% |
66,284
-19,020
| -22% | -$97.4K |
|
2110
Century Aluminum
CENX
$5.07B
| $464K | ﹤0.01% |
65,102
-862
| -1% | -$4.56K |
|
2111
MGP Ingredients
MGPI
$375M
| $463K | ﹤0.01% |
+12,611
| New | +$451K |
|
|
CPRX
2112
DELISTED
Catalyst Pharmaceutical
CPRX
| $463K | ﹤0.01% |
100,153
-490
| -0.5% | -$2.2K |
|
|
FBM
2113
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $460K | ﹤0.01% |
29,480
-4,981
| -14% | -$62.9K |
|
|
BDSI
2114
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $459K | ﹤0.01% |
105,300
-30,250
| -22% | -$136K |
|
|
EBIX
2115
DELISTED
Ebix Inc
EBIX
| $453K | ﹤0.01% |
20,276
| – | – |
|
2116
Ingles Markets
IMKTA
$1.67B
| $452K | ﹤0.01% |
10,497
+258
| +3% | +$10.5K |
|
2117
KALA BIO
KALA
$14.5M
| $452K | ﹤0.01% |
+17
| New | +$482K |
|
2118
Banc of California
BANC
$2.97B
| $452K | ﹤0.01% |
41,701
-4,015
| -9% | -$40.4K |
|
|
HONE
2119
DELISTED
HarborOne Bancorp
HONE
| $450K | ﹤0.01% |
52,672
+8,300
| +19% | +$66.4K |
|
2120
A10 Networks
ATEN
$1.95B
| $448K | ﹤0.01% |
65,758
-15,253
| -19% | -$102K |
|
2121
Triumph Financial Inc
TFIN
$1.82B
| $447K | ﹤0.01% |
18,435
-162
| -0.9% | -$3.97K |
|
|
HNGR
2122
DELISTED
Hanger Inc.
HNGR
| $447K | ﹤0.01% |
26,996
+2,900
| +12% | +$49K |
|
2123
Quince Therapeutics
QNCX
$29.5M
| $447K | ﹤0.01% |
+48
| New | +$440K |
|
|
PDLI
2124
DELISTED
PDL BioPharma, Inc.
PDLI
| $442K | ﹤0.01% |
151,896
-14,433
| -9% | -$45.6K |
|
2125
Option Care Health
OPCH
$3.56B
| $440K | ﹤0.01% |
31,725
+15,700
| +98% | +$208K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.